Skip to search formSkip to main contentSkip to account menu

Prevnar

Known as: Prevenar 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

heptavalent pneumococcal conjugate vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine
Objective: To review the immurtogenicity, efficacy, and safety of the 13-valent pneumococcal conjugate vaccine (PCV13) for use in… 
2009
2009
Simultaneous vaccination with Prevenar and multicomponent vaccines for children: Interference or no interference?
Multicomponent vaccines against as many as six infectious diseases are often given simultaneously with monovalent or multivalent… 
Review
2007
Review
2007
Prevenar vaccination: review of the global data, 2006.
Review
2006
Review
2006
Control of pneumococcal disease in the United Kingdom--the start of a new era.
In 2000, a multi-valent pneumococcal conjugate vaccine, known as Prevnar, was licensed for use in infants and young children in… 
2006
2006
Type-Specific Antibodies to Pneumococcal Capsular Polysaccharide Acquired either Naturally or after Vaccination with Prevenar in Children with Underlying Chronic or Recurrent Lung Diseases
ABSTRACT The antibody response to capsular polysaccharides of pneumococcal serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F elicited… 
2005
2005
Evaluation of the safety and immunogenicity of pneumococcal seven-valent conjugate vaccine (Prevenar) administered in previously unvaccinated Spanish children aged 24 to 36 months.
Review
2004
Review
2004
[Clinical effectiveness of seven-valent pneumococcal conjugate vaccine (Prevenar) against invasive pneumococcal diseases: prospects for children in France].
A seven-valent pneumococcal polysaccharide-CRM197 carrier protein conjugate vaccine (PNC7V; Prevenar, Wyeth, Paris) targets the… 
2004
2004
Impact of Pneumococcal Polysaccharide Vaccine (Prevnar) on Middle Ear Fluid in Children Undergoing Tympanostomy Tube Insertion
Objectives: The purpose of this study was to describe the bacteriology of middle ear effusions in children who have received the… 
2003
2003
Tolérance et immunogénicité d'un vaccin pneumococcique osidique conjugué heptavalent (Prevenar®) administré en association avec une combinaison vaccinale pédiatrique (DTCoq-Polio/Hib) à des…
2003
2003
[The safety and immunogenicity of an heptavalent pneumococcal polysaccharide conjugate vaccine (Prevenar) administered in association with a whole-cell pertussis-based pediatric combination vaccine…
UNLABELLED Invasive pneumococcal disease is presently a leading cause of mortality due to bacterial infectious diseases in French… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)